A complement component c1q-mediated mechanism of antibody-dependent enhancement of ebola virus infection

Wakako Furuyama, Asuka Nanbo, Junki Maruyama, Andrea Marzi, Ayato Takada

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Besides the common Fc receptor (FcR)-mediated mechanism of antibody-dependent enhancement (ADE), Ebola virus (EBOV) is known to utilize the complement component C1q for ADE of infection. This mechanism is FcR-independent and mediated by cross-link-ing of virus-antibody-C1q complexes to cell surface C1q receptors, leading to enhanced viral entry into cells. Using confocal microscopy, we found that virus-like particles (VLPs) consisting of EBOV glycoprotein, nucleoprotein, and matrix protein attached to the surface of human kidney 293 cells more efficiently in the presence of an ADE monoclonal antibody and C1q than with the antibody or C1q alone, and that there was no significant difference in the efficiency of VLP uptake into endosomes between the C1q-mediated ADE and non-ADE entry. Accordingly, both ADE and non-ADE infection were similarly decreased by inhibitors of the signaling pathways known to be required for endocytosis. These results suggest that C1q-mediated ADE of EBOV infection is simply caused by increased attachment of virus particles to the cell surface, which is distinct from the mechanism of FcR-mediated ADE requiring intracellular signaling to promote phagocytosis/macropinocytosis.

Original languageEnglish (US)
Article numbere0008602
Pages (from-to)1-12
Number of pages12
JournalPLoS neglected tropical diseases
Issue number9
StatePublished - Sep 2020
Externally publishedYes

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases


Dive into the research topics of 'A complement component c1q-mediated mechanism of antibody-dependent enhancement of ebola virus infection'. Together they form a unique fingerprint.

Cite this